122
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Impact of methylene-tetrahydrofolate reductase gene C677T and A1298C polymorphisms as a risk factor for hepatitis B virus infection

ORCID Icon, ORCID Icon, , &
Pages 683-695 | Received 27 Jul 2022, Accepted 26 Feb 2023, Published online: 15 Mar 2023

References

  • Rizzetto, M.; Ciancio, A. Chronic HBV-Related Liver Disease. Mol. Aspects Med. 2008, 29, 72–84. DOI: 10.1016/j.mam.2007.09.013.
  • Shi, Y. H.; Shi, C. H. Molecular Characteristics and Stages of Chronic Hepatitis B Virus İnfection. World J. Gastroenterol. 2009, 15, 3099–3105. DOI: 10.3748/wjg.15.3099.
  • Franco, E.; Bagnato, B.; Marino, M. G.; Meleleo, C.; Serino, L.; Zaratti, L. Hepatitis B: Epidemiology and Prevention in Developingcountries. World J. Hepatol. 2012, 4, 74–80. DOI: 10.4254/wjh.v4.i3.74.
  • Terrault, N. A.; Bzowej, N. H.; Chang, K. M.; Hwang, J. P.; Jonas, M. M.; Murad, M. H, American Association for the Study of Liver Diseases AASLD Guidelines for Treatment of Chronic Hepatitis B. Hepatology 2016, 63, 261–283. DOI: 10.1002/hep.28156.
  • Özkan, H. Epidemiology of Chronic Hepatitis B in Turkey. Eur. J. Hepatogastroenterol. 2018, 8, 73–74.
  • Gurol, E.; Saban, C.; Oral, O.; Cigdem, A.; Armagan, A. Trends in Hepatitis B and Hepatitis C Virus among Blood Donors over 16 Years in Turkey. Eur. J. Epidemiol. 2006, 21, 299–305. DOI: 10.1007/s10654-006-0001-2.
  • Wasityastuti, W.; Yano, Y.; Ratnasari, N.; Triyono, T.; Triwikatmani, C.; Indrarti, F.; Heriyanto, D. S.; Yamani, L. N.; Liang, Y.; Utsumi, T.; Hayashi, Y. Protective Effects of HLA-DPA1/DPB1 Variants against Hepatitis B Virus İnfection in an Indonesian Population. Infect Genet. Evol. 2016, 41, 177–184. 2016
  • Wei, Q.; Shen, H.; Wang, L. E.; Duphorne, C. M.; Pillow, P. C.; Guo, Z.; Qiao, Y.; Spitz, M. R. Association between Low Dietary Folate İntake and Suboptimal Cellular DNA Repair Capacity. Cancer Epidemiol. Biomark. Prev. 2003, 12, 963–969.
  • Bailey, L. B.; Gregory, J. F.III. Polymorphisms of Methylenetetrahydrofolate Reductase and Other Enzymes: metabolic Significance, Risks and İmpact on Folate Requirement. J. Nutr. 1999, 129, 919–922. DOI: 10.1093/jn/129.5.919.
  • Goyette, P.; Sumner, J. S.; Milos, R.; Duncan, A. M.; Rosenblatt, D. S.; Matthews, R. G.; Rozen, R. Human Methylenetetrahydrofolate Reductase: isolation of cDNA, Mapping and Mutation İdentification. Nat. Genet. 1994, 7, 195–200. DOI: 10.1038/ng0694-195.
  • Goyette, P.; Pai, A.; Milos, R.; Frosst, P.; Tran, P.; Chen, Z.; Chan, M.; Rozen, R. Gene Structure of Human and Mouse Methylenetetrahydrofolate Reductase (MTHFR). Mamm. Genome 1998, 9, 652–656. DOI: 10.1007/s003359900838.
  • Frosst, P.; Blom, H. J.; Milos, R.; Goyette, P.; Sheppard, C. A.; Matthews, R. G.; Boers, G. J.; den Heijer, M.; Kluijtmans, L. A.; van den Heuvel, L. P. A Candidate Genetic Risk Factor for Vascular Disease: A Common Mutation in Methylenetetrahydrofolate Reductase. Nat. Genet. 1995, 10, 111–113. DOI: 10.1038/ng0595-111.
  • van der Put, N. M.; Gabreëls, F.; Stevens, E. M.; Smeitink, J.; A.; Trijbels, F. J.; Eskes, T. K.; van den Heuvel, L. P.; Blom, H. J. A Second Mutation in the Methylenetetrahydrofolate Reductase Gene: An Additional Risk Factor for Neural-Tube Defects? Am. J. Hum. Genet. 1998, 62, 1044–1051. DOI: 10.1086/301825.
  • Lok, A. S. F.; McMahon, B. J. AASLD Practice Guidelines Chronic Hepatitis B: Update 2009. Hepatology 2009, 50, 661–662. DOI: 10.1002/hep.23190.
  • Rozen, R. Genetic Predisposition to Hyperhomocysteinemia:deficiency of Methylenetetrahydrofolate Reductase (MTHFR). Thromb. Haemost. 1997, 78, 523–526.
  • Bronowicki, J. P.; Abdelmouttaleb, I.; Peyrin-Biroulet, L.; Venard, V.; Khiri, H.; Chabi, N.; Amouzou, E. K.; Barraud, H.; Halfon, P.; Sanni, A.; et al. Methylenetetrahydrofolate Reductase 677 T Allele Protects against Persistent HBV İnfection in West Africa. J. Hepatol. 2008, 48, 532–539. DOI: 10.1016/j.jhep.2007.11.017.
  • Jiao, X.; Luo, Y.; Yang, B.; Jing, L.; Li, Y.; Liu, C.; Jing, X.; Wang, F.; Wang, Y.; Du, Z.; Gao, Y. The MTHFR C677T Mutation is Not a Risk Factor Recognized for HBV-Related HCC in a Population with a High Prevalence of This Genetic Marker. Infect Genet. Evol. 2017, 49, 66–72. DOI: 10.1016/j.meegid.2017.01.008.
  • Zhang, S.; Jiang, J.; Tang, W.; Liu, L. Methylenetetrahydrofolate Reductase C677T (Ala > Val, rs1801133 C > T) Polymorphism Decreases the Susceptibility of Hepatocellular Carcinoma: A Meta-Analysis İnvolving 12,628 Subjects. Biosci. Rep. 2020, 40, BSR20194229.
  • Ponti, G.; Pastorino, L.; Manfredini, M.; Ozben, T.; Oliva, G.; Kaleci, S.; Iannella, R.; Tomasi, A. COVID-19 Spreading across World Correlates with C677T Allele of the Methylenetetrahydrofolate Reductase (MTHFR) Gene Prevalence. J. Clin. Lab. Anal. 2021, 35, e23798. DOI: 10.1002/jcla.23798.
  • Carvalho, S.; Vasconcelos, L.; Fonseca, L. D.; Carmo, R. F.; Tomitão, M. T.; Aroucha, D.; Pereira, L.; Stefano, J. T.; Ribeiro-Júnior, U.; Oliveira, C. P.; Carrilho, F. J. Methylene Tetrahydrofolate Reductase (MTHFR) and Vascular Endothelial Growth Factor (VEGF) Polymorphisms in Brazilian Patients with Hepatitis C Virus (HCV)-Related Hepatocellular Carcinoma (HCC). Clinics (Sao Paulo) 2021, 76, e2881. DOI: 10.6061/clinics/2021/e2881.
  • Karakus, N.; Duygu, F.; Rustemoglu, A.; Yigit, S. Methylene-Tetrahydrofolate Reductase Gene C677T and A1298C Polymorphisms as a Risk Factor for Crimean-Congo Hemorrhagic Fever. [Published Online Ahead of Print, 2022 Jun 6] [Published Correction Appears in Nucleosides Nucleotides Nucleic Acids. 2022 Jul 19;:1-2]. Nucleosides Nucleotides Nucleic Acids 2022, 41(9), 878–890.
  • Duthie, S.; J. Folate and Cancer: how DNA Damage, Repair and Methylation İmpact on Colon Carcinogenesis. J. Inherit. Metab. Dis. 2011, 34, 101–109. DOI: 10.1007/s10545-010-9128-0.
  • Hiraoka, M.; Kagawa, Y. Genetic Polymorphisms and Folate Status. Congenit. Anom. (Kyoto) 2017, 57, 142–149. DOI: 10.1111/cga.12232.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.